Corpus Intelligence IC Memo — CORDOVA COMMUNITY MEDICAL CENTER 2026-04-26 04:04 UTC
IC Memo — CORDOVA COMMUNITY MEDICAL CENTER
Investment Committee Memorandum | AK | 13 beds | Grade D | EBITDA uplift $905K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CORDOVA COMMUNITY MEDICAL CENTER

CCN 021307 | CORDOVA, AK | 13 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CORDOVA COMMUNITY MEDICAL CENTER is a 13-bed safety-net/medicaid heavy in CORDOVA, AK with $12.3M in net patient revenue and a -5.5% operating margin. The hospital serves a payer mix of 51.9% Medicare, 38.1% Medicaid, and 10.0% commercial.

Thesis: Turnaround. Our ML models identify $905K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.5% to 1.9% (+739bps).

Net Revenue HCRIS$12.3M
Current EBITDA COMPUTED$-671K
Operating Margin COMPUTED-5.5%
Occupancy HCRIS17.6%
Revenue / Bed COMPUTED$943K
Net-to-Gross HCRIS72.4%
Distress Probability ML69.0%

2. Market Context & Competitive Position

24
AK Hospitals
-2.1%
State Median Margin
11
Comparable Hospitals

AK has 24 Medicare-certified hospitals with a median operating margin of -2.1%. The target's margin of -5.5% places it below the state median. Among 11 size-comparable peers (6-26 beds), the median margin is -11.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (6-26), prioritizing same-state peers. 11 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CORDOVA COMMUNITY MEDICAL CENT (Target)AK13$12.3M-5.5%
NORTON SOUND REGIONAL HOSPITALAK18$148.7M-28.6%
SOUTH PENINSULA HOSPITALAK21$112.1M-3.4%
KETCHIKAN MEDICAL CENTERAK25$92.4M-13.1%
PROV. KODIAK ISLAND MEDICAL CEAK24$59.6M-0.6%
SAMUEL SIMMONDS MEMORIAL HOSPIAK10$57.8M-50.0%
ALASKA SPECIALTY HOSPITAL LLCAK26$38.7M-29.0%
PROVIDENCE VALDEZ MEDICAL CENTAK11$20.0M8.4%
PETERSBURG MEDICAL CENTERAK12$19.5M-10.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $905K (739bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$257K+210bp18mo
Cost to Collect4.5%2.5%$245K+200bp12mo
Denial Rate Reduction12.0%6.5%$244K+199bp12mo
A/R Days Reduction5200.0%3800.0%$149K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+8bp6mo

5. EBITDA Bridge

Net Collection Rate
$257K
Cost to Collect
$245K
Denial Rate Reduction
$244K
A/R Days Reduction
$149K
Clean Claim Rate
$10K
Total EBITDA Uplift$905K
Current EBITDA$-671K
+ RCM Uplift+$905K
Pro Forma EBITDA$235K
Current Margin-5.5%
Pro Forma Margin1.9%
WC Released (1x)$470K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.0M$4.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.0M$4.8M0.00x-100.0%
Bull Case9.0x11.0x$-928K$7.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-928K$7.8M0.00x-100.0%
Bear Case11.0x10.0x$-1.1M$438K0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.1M$113K0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (38.1%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
MediumLow occupancyAt 17.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 69.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 11 hospitals with 6-26 beds
  • Same-state prioritization (n=13)
  • Comp margins: P25=-28.7% / P50=-11.9% / P75=-2.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.